title: CMV hyperimmune globulin prophylaxis after liver transplantation: a prospective randomized controlled study.
authors.affiliation: Unité de Chirurgie Hepato-Biliare, Hôpital Paul Brousse, Villejuif, France.
authors.forename: F
authors.initials: F
authors.lastname: Saliba
authors.forename: J L
authors.initials: JL
authors.lastname: Arulnaden
authors.forename: J
authors.initials: J
authors.lastname: Gugenheim
authors.forename: C
authors.initials: C
authors.lastname: Serves
authors.forename: D
authors.initials: D
authors.lastname: Samuel
authors.forename: A
authors.initials: A
authors.lastname: Bismuth
authors.forename: D
authors.initials: D
authors.lastname: Mathieu
authors.forename: H
authors.initials: H
authors.lastname: Bismuth
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage*; D007167:Immunotherapy; D016031:Liver Transplantation; D008297:Male; D011446:Prospective Studies; D011897:Random Allocation
chemical_list: D000914:Antibodies, Viral; D007136:Immunoglobulins